MLL (mixed-lineage-leukemia) gene rearrangements at 11q23 are present in 80% of all infant B-ALL cases and 10% of all childhood B-ALL [38,39]. This evidence concerns the gene KMT2A and precursor B-cell acute lymphoblastic leukemia.